Solicitation of Nominations for Appointment to the Advisory Council for the Elimination of Tuberculosis, 23427 [2023-07992]
Download as PDF
23427
Federal Register / Vol. 88, No. 73 / Monday, April 17, 2023 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Form name
All jurisdictions with current or potential funding support through
CDC–RFA–DP19–1908, CDC–RFA–DP22–2211, and CDC–RFA–
DP–23–0066.
MMRIA committee decision form.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2023–07995 Filed 4–14–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory Council
for the Elimination of Tuberculosis
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Advisory
Council for the Elimination of
Tuberculosis (ACET). ACET consists of
10 experts including the Chair in fields
associated with public health,
epidemiology, immunology, infectious
diseases, pulmonary disease, pediatrics,
tuberculosis, microbiology, and
preventive health care delivery.
DATES: Nominations for membership on
ACET must be received no later than
August 31, 2023. Packages received after
this time will not be considered for the
current membership cycle.
ADDRESSES: All nominations should be
emailed to nchhstppolicy@cdc.gov with
the subject line ‘‘ACET 2024
Nomination’’ or faxed to (404) 639–
8600.
FOR FURTHER INFORMATION CONTACT:
Marah Condit, MS, Committee
Management Lead, Office of Policy,
Planning, and Partnerships, National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop US8–6, Atlanta,
Georgia 30329–4027. Telephone: (404)
639–3423; Email: MCondit@cdc.gov.
SUPPLEMENTARY INFORMATION: The
Advisory Council for the Elimination of
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
16:57 Apr 14, 2023
Jkt 259001
Tuberculosis (ACET) provides advice
and recommendations regarding the
elimination of tuberculosis (TB) to the
Secretary, Department of Health and
Human Services (HHS); the Assistant
Secretary for Health, HHS; and the
Director, Centers for Disease Control
and Prevention (CDC). ACET (a) makes
recommendations on policies, strategies,
objectives, and priorities; (b) addresses
development and application of new
technologies; (c) provides guidance and
review of CDC’s TB prevention research
portfolio and program priorities; and (d)
reviews the extent to which progress has
been made toward eliminating TB.
Nominations are sought for persons
who have expertise and qualifications
necessary to contribute to the
accomplishment of the objectives of
ACET. Nominees will be selected on the
basis of their expertise in public health,
epidemiology, immunology, infectious
diseases, pulmonary disease, pediatrics,
tuberculosis, microbiology, or
preventive health care delivery. Federal
employees will not be considered for
membership. Members may be invited
to serve for up to four-year terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACET
objectives.
HHS policy stipulates that committee
membership be balanced in terms of
points of view represented and the
committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning of and annually during their
terms. CDC reviews potential candidates
PO 00000
Frm 00038
Fmt 4703
Sfmt 9990
Number of
respondents
Number of
responses per
respondent
53
Average
burden per
response
(in hours)
42
24/60
for ACET membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2024, or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. Candidates should
submit the following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
and email address).
D At least one letter of
recommendation from person(s) not
employed by HHS. Candidates may
submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (i.e., CDC,
National Institutes of Health, Food and
Drug Administration, etc.).
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–07992 Filed 4–14–23; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\17APN1.SGM
17APN1
Agencies
[Federal Register Volume 88, Number 73 (Monday, April 17, 2023)]
[Notices]
[Page 23427]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07992]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Council for the Elimination of Tuberculosis
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), within
the Department of Health and Human Services (HHS), is seeking
nominations for membership on the Advisory Council for the Elimination
of Tuberculosis (ACET). ACET consists of 10 experts including the Chair
in fields associated with public health, epidemiology, immunology,
infectious diseases, pulmonary disease, pediatrics, tuberculosis,
microbiology, and preventive health care delivery.
DATES: Nominations for membership on ACET must be received no later
than August 31, 2023. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be emailed to [email protected]
with the subject line ``ACET 2024 Nomination'' or faxed to (404) 639-
8600.
FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management
Lead, Office of Policy, Planning, and Partnerships, National Center for
HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6, Atlanta,
Georgia 30329-4027. Telephone: (404) 639-3423; Email: [email protected].
SUPPLEMENTARY INFORMATION: The Advisory Council for the Elimination of
Tuberculosis (ACET) provides advice and recommendations regarding the
elimination of tuberculosis (TB) to the Secretary, Department of Health
and Human Services (HHS); the Assistant Secretary for Health, HHS; and
the Director, Centers for Disease Control and Prevention (CDC). ACET
(a) makes recommendations on policies, strategies, objectives, and
priorities; (b) addresses development and application of new
technologies; (c) provides guidance and review of CDC's TB prevention
research portfolio and program priorities; and (d) reviews the extent
to which progress has been made toward eliminating TB.
Nominations are sought for persons who have expertise and
qualifications necessary to contribute to the accomplishment of the
objectives of ACET. Nominees will be selected on the basis of their
expertise in public health, epidemiology, immunology, infectious
diseases, pulmonary disease, pediatrics, tuberculosis, microbiology, or
preventive health care delivery. Federal employees will not be
considered for membership. Members may be invited to serve for up to
four-year terms. Selection of members is based on candidates'
qualifications to contribute to the accomplishment of ACET objectives.
HHS policy stipulates that committee membership be balanced in
terms of points of view represented and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens and cannot be full-time employees of the
U.S. Government. Current participation on federal workgroups or prior
experience serving on a federal advisory committee does not disqualify
a candidate; however, HHS policy is to avoid excessive individual
service on advisory committees and multiple committee memberships.
Committee members are Special Government Employees, requiring the
filing of financial disclosure reports at the beginning of and annually
during their terms. CDC reviews potential candidates for ACET
membership each year and provides a slate of nominees for consideration
to the Secretary of HHS for final selection. HHS notifies selected
candidates of their appointment near the start of the term in July
2024, or as soon as the HHS selection process is completed. Note that
the need for different expertise varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year. Candidates should submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, and email address).
[ssquf] At least one letter of recommendation from person(s) not
employed by HHS. Candidates may submit letter(s) from current HHS
employees if they wish, but at least one letter must be submitted by a
person not employed by an HHS agency (i.e., CDC, National Institutes of
Health, Food and Drug Administration, etc.).
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-07992 Filed 4-14-23; 8:45 am]
BILLING CODE 4163-18-P